CDK4 and neoplasm: Bai et al. focused on the application of an MOF photosensitive nanointerferer to increase tumor cells intrinsic immunogenicity and mobilize the immune system to identify and eradicate tumors by inhibiting Cyclin-dependent kinase 4 (Cdk4) and activating PDT to promote immunogenic tumor antigen production and presentation.